← Back to Analyst Consensus 
HRTX Hold
HERON THERAPEUTICS, INC. /DE/
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 10, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 11, 2026 | HC Wainwright & Co. | downgrade | Buy → Neutral | — | 44% |
| Jun 3, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jun 3, 2026 | Needham | downgrade | Buy → Hold | — | 50% |
| Jan 9, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Aug 8, 2025 | Needham | maintain | Buy → Buy | $3 | 50% |
| Jun 9, 2025 | HC Wainwright & Co. | initiate | — → Buy | $6 | 44% |
| Apr 11, 2025 | Needham | reiterate | Buy → Buy | $4 | 50% |
| Feb 28, 2025 | Needham | reiterate | Buy → Buy | $4 | 50% |
| Dec 4, 2024 | Needham | reiterate | Buy → Buy | $4 | 50% |
| Nov 13, 2024 | Needham | maintain | Buy → Buy | $4 | 50% |
| Sep 25, 2024 | Needham | reiterate | Buy → Buy | $5 | 50% |
| Aug 7, 2024 | Needham | reiterate | Buy → Buy | $5 | 50% |
| Jun 13, 2024 | Rodman & Renshaw | initiate | — → Buy | $7 | 40% |
| May 16, 2024 | Needham | reiterate | Buy → Buy | $5 | 50% |
| May 8, 2024 | Needham | reiterate | Buy → Buy | $5 | 50% |
| Apr 23, 2024 | Capital One | initiate | — → Overweight | $6 | 30% |
| Apr 11, 2024 | Needham | reiterate | Buy → Buy | $5 | 50% |
| Mar 13, 2024 | Needham | maintain | Buy → Buy | $5 | 50% |
| Nov 15, 2023 | Needham | maintain | Buy → Buy | $4 | 50% |
| Aug 15, 2023 | Needham | reiterate | Buy → Buy | $5 | 50% |
| Jul 25, 2023 | Needham | maintain | Buy → Buy | $5 | 50% |
| May 12, 2023 | Needham | maintain | Buy → Buy | $6 | 50% |
| Apr 21, 2023 | Needham | reiterate | — → Buy | $7 | 50% |
| Mar 24, 2023 | Evercore ISI Group | maintain | — → Outperform | $10 | 58% |
| Mar 24, 2023 | Needham | maintain | — → Buy | $7 | 50% |
| Nov 9, 2022 | Needham | maintain | — → Buy | $8 | 50% |
| Jun 30, 2022 | Needham | maintain | — → Buy | $10 | 50% |
| May 10, 2022 | Needham | maintain | — → Buy | $14 | 50% |
| Dec 2, 2020 | SVB Leerink | maintain | — → Outperform | $24 | — |
| May 27, 2020 | Guggenheim | initiate | — → Buy | $24 | 52% |
| Mar 2, 2020 | Needham | maintain | — → Buy | $44 | 50% |
| Feb 20, 2020 | Needham | maintain | — → Buy | $48 | 50% |
| Oct 3, 2019 | JMP Securities | reiterate | — → Market Outperform | $32 | 53% |
| Sep 14, 2018 | Stifel | initiate | — → Buy | $55 | 53% |
| Jul 19, 2018 | Cantor Fitzgerald | maintain | Overweight → Overweight | $50 | 50% |
| Jun 22, 2018 | Oppenheimer | maintain | Outperform → Outperform | $50 | 52% |
| Jun 21, 2018 | Evercore ISI Group | maintain | — → Outperform | $80 | 58% |
| Jan 3, 2018 | Leerink Swann | initiate | — → Outperform | $22 | — |
| Oct 31, 2017 | Oppenheimer | initiate | — → Outperform | $27 | 52% |
| Sep 27, 2017 | Northland Capital Markets | initiate | — → Outperform | $0 | 50% |
| Sep 27, 2017 | Mizuho | initiate | — → Buy | $28 | 52% |
| Feb 27, 2017 | Needham | initiate | — → Buy | $28 | 50% |
| Oct 26, 2016 | Aegis Capital | initiate | — → Buy | $0 | — |
| Oct 3, 2016 | Jefferies | maintain | — → Buy | $40 | 52% |
| May 2, 2016 | Cantor Fitzgerald | initiate | — → Buy | $41 | 50% |
| Dec 10, 2015 | Lake Street | initiate | — → Buy | $45 | 47% |
| Sep 23, 2015 | Brean Capital | maintain | — → Buy | $55 | — |
| Sep 23, 2015 | JMP Securities | maintain | — → Market Outperform | $56 | 53% |
| Sep 23, 2015 | Jefferies | maintain | — → Buy | $58 | 52% |
| Sep 2, 2015 | B of A Securities | initiate | — → Buy | $46 | 53% |
Price Target Trend
Apr 26, 2026 Oct 26, 2026
EPS Estimates
+1y —
+1q —
0q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days